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Neuropathic pain refers to pain that originates from pa-
thology of the nervous system. Diabetes, infection (her-
pes zoster),nervecompression, nerve trauma, ‘‘channe-
lopathies,’’ and autoimmune disease are examples of
diseases thatmaycause neuropathic pain. The develop-
mentofbothanimalmodels and newer pharmacological
strategies has led to an explosion of interest in the un-
derlying mechanisms. Neuropathic pain reflects both
peripheral and central sensitization mechanisms. Ab-
normal signals arise not only from injured axons but
also from the intact nociceptors that share the innerva-
tionterritoryof the injurednerve.This reviewfocuseson
how both human studies and animal models are helping
to elucidate the mechanisms underlying these surpris-
ingly common disorders. The rapid gain in knowledge
about abnormal signaling promises breakthroughs in
the treatment of these often debilitating disorders.
Chronic pain has been estimated to affect one-sixth of
the population. The phrase ‘‘neuropathic pain’’ came
into common use only in the last decade and increasingly
has been appreciated as a frequent source of chronic
pain, perhaps trailing only osteoarthritis as a cause.
Neuropathic pain results from pathology in the nervous
system. Consider the following clinical presentation:
A 47-year-old woman presented for consultation for
complaints of pain on the right chest wall. The patient
underwent a mastectomy on the right side as a treatment
for cancer 5 years previously. As the surgical pain faded,
the patient noted increasing chest-wall pain that ex-
tended well beyond the surgical borders. Clothing lightly
touching the skin increased the pain. Reconstructive
surgery was deferred because of concerns about the
ongoing pain. In addition to the ongoing burning pain,
the patient also complained of sudden ‘‘pain attacks’’
one to several times a day. These attacks lasted sec-
onds to minutes and were described as debilitating.
Examination revealed a well-healed surgical scar. Light
stroking of the skin provoked significant pain in an
area from the clavicle down to the T8 dermatome. De-
spite the pain to light tactile stimuli, the patient also
had areas of decreased sensibility as demonstrated by
the inability to detect a fine probe applied to the skin.
The above case represents a classical presentation of
a patient with neuropathic pain. The notable features
that point to neuropathic processes are as follows:
 Widespread pain not otherwise explainable
 Evidence of sensory deficit
 Burning pain
 Pain to light stroking of the skin
 Attacks of pain without seeming provocation
*Correspondence: jcampbel@jhmi.eduThe liability for pain appears to vary from person to
person, from nerve to nerve, between males and fe-
males, and even with age. What appears to be the
same lesion may induce no pain in one person but se-
vere pain in another. In addition to ongoing pain (i.e.,
stimulus-independent pain), patients may have height-
ened pain to stimuli applied to their skin. This enhanced
stimulus-dependent pain is called hyperalgesia. In some
patients, lightly stoking the skin may evoke pain. This
pain to light touch is often called allodynia (Treede
et al., 1992).
In this review, we will focus on the mechanisms of
neuropathic pain. Lesions of the CNS (e.g., spinal
cord) and peripheral nerves may lead to pain, but the
majority of experimental studies have focused on con-
sequences of lesions of peripheral nerves, and there-
fore, we will focus on this area in this review.
Anatomical Considerations
Neuropathic pain is distinguished from other pain condi-
tions where the pain generator begins with disease of
nonneural tissues. These nonneuropathic pain entities
are said to be nociceptive and include conditions such
as osteoarthitis and inflammatory pain. By definition,
neuropathic pain originates from a lesion of the nervous
system. Innumerable diseases may be the culprits. Ex-
amples include autoimmune disease (e.g., multiple scle-
rosis), metabolic diseases (e.g., diabetic neuropathy),
infection (e.g., shingles and the sequel, postherpetic
neuralgia), vascular disease (stroke), trauma, and can-
cer. A rule without apparent exception is that the lesion
leading to pain must directly involve the nociceptive
pathways (Boivie et al., 1989). Accordingly, for example,
lesions of the medial lemniscal system (e.g., dorsal col-
umns) do not induce pain (Cook and Browder, 1965).
Whereas evidence supports the hypothesis that pain-
generating lesions of the nervous system must involve
the nociceptive pathways, the converse clearly does
not hold up. Namely, not all lesions of nociceptive path-
ways induce pain. A lesion of the peripheral nerve may
induce pain, but simply severing dorsal roots seems to
have little chance of creating lasting pain (Li et al.,
2000). For example, dorsal roots are cut to treat spastic-
ity and sometimes to remove tumors. The authors know
of no case of neuropathic pain arising from these types
of lesions in man. Here, we do not take up the issue of
CNS lesions, but it is nevertheless worth noting that
though spinal cord lesions carry a substantial risk of in-
ducing pain, some evidence suggests that the lesion
must include the gray matter. Vireck has found that sim-
ple cordotomy where only the white matter is lesioned
does not induce abnormal pain behavior in a primate
model, whereas lesions that include the gray matter
may (Vierck and Light, 1999). Lesions of the brainstem
and thalamus carry a risk of causing pain if the nocicep-
tive pathways are involved (Boivie, 2006). In nearly all of
these cases, there is the paradoxical juxtaposition of on-
going pain and a sensory deficit to noxious stimulation
(even when hyperalgesia is present). Lesions confined
to the cortex appear not to be associated with abnormal
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78Table 1. Examples of Neuropathic Pain Conditions
Disease Pathology Symptoms Hyperalgesia Special Features
Cooling Heat Mechanical
Traumatic neuropathy Axotomy distal to DRG Ongoing pain ++ + ++ Great variety of presentations
Tic douloureux Compression (often vascular)
of trigeminal nerve
near brainstem
Lightening-like
attacks of pain
? ? +++ Mechanical stimuli
evoke attacks of pain
Painful diabetic
neuropathy
Length-dependent
neuropathy
Burning pain
in the feet
2 + +/2 Neuropathy sometimes affects
small fibers exclusively
Postherpetic neuralgia Results from damage by
herpes zoster infection
of peripheral nerve
Burning pain +/2 +/2 ++ Pain follows the distribution of
the affected dermatomespain (but it is also unclear whether lesions confined to
the cerebral cortex induce deficits of pain sensibility
[Head and Holmes, 1911]).
Nervous System Diseases Associated with Pain
As noted above, a rich variety of diseases of the nervous
system are associated with pain (Table 1) (Scadding and
Koltzenburg, 2006). In the introduction, a case of trau-
matic painful neuropathy was presented (Campbell,
2001). The offending lesion may involve a simple axot-
omy (cutting of the nerve) or merely nerve entrapment.
Ongoing pain may be the only manifestation, but in
many cases, hyperalgesia with pain to light-stroking
stimuli (allodynia) may be manifest. In some cases, there
is striking cooling hyperalgesia, where mild lowering of
skin temperature exacerbates the pain. Weir Mitchell
described a striking variant of neuropathic pain that he
termed causalgia (Lau and Chung, 2004). He noted this
condition in patients who had missile lesions of an
extremity. Patients presented with striking edema,
profound autonomic features (abnormal sweating and
either hot or cold skin), and devastating pain. A similar
presentation can occur without a clear nerve injury,
and presently, this is referred to as ‘‘complex regional
pain syndrome (CRPS), type 1.’’ Where a clear nerve le-
sion is manifest, the condition is referred to as CRPS,
type 2 (Stanton-Hicks et al., 1995).
One of the classic examples of neuropathic pain is Tic
douloureux. Without treatment, this is a debilitating dis-
order that involves attacks of severe pain in the facial
area (also referred to as trigeminal neuralgia). Often
there is little or no pain between attacks. The lighten-
ing-like attacks are referred to one of the dermatomes
(V1, V2, or V3). Light touching of the skin in a so-called
trigger zone suffices to evoke an attack. The disease ap-
pears to be associated with mechanical distortion at the
entry zone of the nerve root to the brainstem. Demyelin-
ation may be seen at the compression site. Nerve com-
pression from an aberrant blood vessel is one of the
more common causes (Elias and Burchiel, 2002).
Another classical neuropathic pain condition is painful
diabetic neuropathy (Dyck et al., 2000). Diabetes often
causes a length-dependent neuropathy (meaning that
the longest axons in the peripheral nerve are most vul-
nerable). Patients report bilateral burning pain in the
toes and feet. Quantitative sensory testing reveals de-
creased pain sensibility (with or without decreased touch
sensibility).Postherpetic neuralgia is a complication of shingles
and is an example of how an infection can lead to pain.
Shingles results from an activation of the herpes zoster
virus that takes up residence in the dorsal root ganglion
after a chickenpox infection. The shingles eruption con-
sists of blisters that follow the dermatome(s) of one or
more spinal nerves. The blisters heal in time, but the
pain may continue. Allodynia is a particularly prominent
feature of postherpetic neuralgia. This allodynia may
be present even with loss of C-fiber innervation of the
epidermis.
The clinical manifestations vary with the type of dis-
ease (Table 1). These variations suggest different mech-
anisms. These differences in mechanism may also be
reflected in responses to therapy. Tic douloureux re-
sponds nicely to treatment with the anticonvulsant car-
bamazepine. Responses to carbamazepine for other
conditions are typically disappointing. Painful diabetic
neuropathy leads to ongoing pain, but allodynia is dis-
tinctly unusual, and cooling may relieve pain. In con-
trast, allodynia is prominent in traumatic neuropathy
and cooling often causes severe pain.
Animal Models of Neuropathic Pain
Whereas the distinction between nociceptive and neu-
ropathic pain has utility, in the actual clinical setting,
the mechanisms are often intertwined (e.g., back pain
with radiculopathy). Fortunately, however, this need not
be the case with regard to animal models. A great ad-
vance in the study of neuropathic pain emanated from
the discovery that placement of loose chromic ligatures
on the sciatic nerve in rat brought about behavior that
appeared analogous to human neuropathic pain condi-
tions (Bennett and Xie, 1988). The rats engaged in pro-
tective behavior and had lowered thresholds to heat,
cooling, and mechanical stimuli.
Subsequent work indicated that an idiosyncratic im-
mune-mediated response to the chromic suture played
a major role in the development of the model (Maves
et al., 1993). The nerve swelled, leading to nerve com-
pression and axotomy. But can an axotomy by itself in-
duce pain? The answer is unequivocally yes. Chung and
colleagues (Kim and Chung, 1992) devised a now fre-
quently used model in rat whereby one or more spinal
nerves that innervates the foot is cut (SNL model in
Figure 1A). A substantial innervation of the foot remains,
reflecting input from the adjacent spinal nerves. This re-
maining innervation allows tests for hyperalgesia to be
undertaken. A simple axotomy provides a foundation
Review
79Figure 1. Animal Models of Neuropathic Pain
(A) Four different nerve injury models are shown. In the spinal nerve ligation (SNL) model, one or more spinal nerves going to the foot are ligated
and cut (Kim and Chung, 1992). In the partial sciatic ligation (PSL) model, a portion of the sciatic nerve is tightly ligated (Seltzer et al., 1990). The
chronic constriction injury (CCI) model involves placement of four loose chromic-gut ligatures on the sciatic nerve. An immune response to the
sutures leads to nerve swelling and nerve constriction. In the spared nerve injury (SNI) model, the common peroneal and tibial nerves are cut,
sparing the sural nerve (Decosterd and Woolf, 2000). In each model, only a portion of the afferents going to the foot are lesioned.
(B and C) Each of these nerve injury models leads to hyperalgesia, which is manifest by enhanced responses to mechanical, heat, and/or cooling
stimuli. (B) To test for mechanical hyperalgesia, Von Frey monofilaments with different bending forces are applied to the plantar surface of the
foot. The threshold force for paw withdrawal decreases dramatically after the nerve injury (adapted with permission [Li et al., 2000]). (C) To test for
heat hyperalgesia, a radiant heat source is focused onto the plantar surface of the foot, and the reaction time for paw withdrawal is measured.
The difference in reaction time between the ipsilateral and contralateral foot is calculated. After the SNL, the withdrawal of the ipsilateral foot is
faster than the contralateral foot (negative latency difference), indicating the presence of heat hyperalgesia (adapted from Kim and Chung [1992]
reprinted from Pain, pp. 355–363, copyright 1992, with permission from the International Association for the Study of Pain).
Data are presented as mean 6 SEM.by which to study mechanism in diseases where axot-
omy is part of the disease process. Some of the common
traumatic nerve injury models are illustrated in Figure 1A.
These injuries lead to hyperalgesia (Figures 1B and 1C).
Trauma has not been the only model used in studies of
neuropathic pain. One of the leading causes of pain in hu-
mans is diabetic neuropathy. Injection of streptozotocin
leads to an animal model of diabetes and is associated
with the development of neuropathy, similar to what is
seen in humans. Hyperalgesia can be measured in ro-
dent models, thus providing a means to study treatments
and mechanisms of pain in this neuropathy model (Ahlg-
ren and Levine, 1993). One of the dose-limiting problems
in chemotherapy is neuropathy, and these neuropathies
are often associated with pain. Animal models of pacli-
taxel and vincristine-induced painful neuropathies have
been developed (Flatters and Bennett, 2004).
Though hyperalgesia is relatively easy to demonstrate
in animal models, the measurement of ongoing pain is
more problematic. This issue is important because on-
going pain without clear hyperalgesia appears to be a
common occurrence in humans (Basbaum et al., 2006).
Substantial denervation of a limb in rat often leads to au-
totomy behavior. Some have advocated that autotomy
is an indication of ongoing pain, the presumed rationale
being that the animal desires to eliminate the painful
body part (Devor, 1991). An alternative explanation is
that the animal chews an anesthetic part for reasons un-related to pain. Some have argued that spontaneous
foot lifting may provide a behavioral measure of sponta-
neous pain (Djouhri et al., 2006). Alternative measures of
ongoing pain involve the use of cellular markers of in-
creased neuronal activity. Increased expression of the
immediate early gene protein, c-Fos, in the dorsal horn
(and perhaps other more rostral sites) is an example
(Bullitt, 1990). Small-animal functional magnetic reso-
nance imaging (fMRI) and/or PET imaging may in the fu-
ture offer alternative measures.
Animal models of neuropathic pain in some cases
have been inconsistent with human models. Allodynia
in painful diabetic neuropathy in humans is infrequent
yet appears to be robust in rat models. NK1 antagonists
appeared to have promise for treatments of pain based
on animal models yet to date have not proven useful in
patients. Vierck (2006) argues that ‘‘reflex’’ measures
of pain in animal neuropathic models are intrinsically
flawed and are neither sensitive nor specific predictors
of drug efficacy in man. For example, he points out
that the paw-withdrawal threshold method tests motor
neuron response rather than simply providing a measure
of pain. Moreover, he indicates that rostral signaling
pathways may be ignored when one merely measures
the paw-withdrawal threshold. His solution is to utilize
operant models.
However, operant measures may be flawed as well
in that they introduce other complexities such as
Neuron
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tion of how much pain is felt. Furthermore, the simple
paw-withdrawal technique has in fact demonstrated
some consistency with human pain studies. In a recent
pharmacological study that used a paw-withdrawal
method in rodents with the SNL model (LaBuda and Lit-
tle, 2005), hyperalgesia was reversed with gabapentin,
amitriptyline, and fluoxetine, but not indomethacin,
treatment. This correlates with the observation that the
first three drugs are useful in treatment of neuropathic
pain in humans but that nonsteroidal drugs are in gen-
eral not useful.
A careful comparison of operant and reflex models in
terms of their predictive capacity has yet to be per-
formed. For drugs with a predominantly supraspinal
action, operant measures may be more appropriate,
whereas simple paw-withdrawal thresholds may be suf-
ficient for drugs that work at peripheral or dorsal horn
targets. Though the particulars of how pain is assessed
remain an issue, a greater concern may relate to sub-
stantial inherent differences in the biology of nocicep-
tion in rodent and man. Regardless of this, new drugs
for treatment of neuropathic pain have been developed,
and their utility in animal models played an influential
role in moving these treatments into clinical trials.
Secondary Hyperalgesia and Central Sensitization
A starting place in understanding neuropathic pain is to
consider what happens with injury to nonneural tissues.
Skin injury produces ongoing pain and two types of hy-
peralgesia: primary and secondary (Meyer et al., 2006).
Primary hyperalgesia occurs at the site of tissue injury
and is mediated in part by sensitization of primary
afferent nociceptors. This is reflected by increased re-
sponses to heat stimuli, for example. Secondary hyper-
algesia occurs in the uninjured tissue surrounding the
site of injury and is thought to be due to sensitization
in the central nervous system. Secondary hyperalgesia
is characterized by hyperalgesia to mechanical, but not
heat, stimuli. This mechanical hyperalgesia is compara-
ble to the hyperalgesia seen in patients with neuropathic
pain. Two types of mechanical hyperalgesia are ob-
served: pain to light-stroking stimuli (i.e., allodynia)
and enhanced pain to punctate stimuli.
Two psychophysical studies in human volunteers pro-
vide strong evidence that secondary hyperalgesia is due
to sensitization in the central nervous system. In both
studies, intradermal injection of capsaicin, the algesic
substance in hot peppers, was used to produce a large
zone of secondary hyperalgesia. In the first study, the
nerve supplying the area to be injected was anesthe-
tized with a local anesthetic (LaMotte et al., 1991). Injec-
tion of capsaicin still produced a large flare, consistent
with the concept that the flare reflects a peripherally me-
diated release of vasoactive peptides subsequent to
antidromic spread of action potentials in the nociceptive
terminals. In the opposite control arm, capsaicin injec-
tion at the same time produced intense pain and a large
zone of secondary hyperalgesia. When the anesthesia
wore off, no zone of mechanical hyperalgesia was found
in the test arm, but hyperalgesia persisted in the control
arm. This experiment provides evidence that the bar-
rage of nociceptor activity associated with the capsaicininjection leads to an altered central processing of input
from mechanosensitive afferents.
In the second study, a fine electrode was placed into
the superficial peroneal nerve (Torebjo¨rk et al., 1992).
Electrical intraneural microstimulation produced a non-
painful tactile percept that was referred to a small
zone on the top of the foot. Capsaicin was injected
adjacent to this area so that the zone of secondary hy-
peralgesia overlapped the area of referred sensation.
Microstimulation after the injection produced a painful
percept. Because this stimulation bypasses any periph-
eral sensitization processes at the cutaneous receptor,
this experiment also provides evidence for altered cen-
tral processing of mechanoreceptor input. Additional
studies have shown that the tactile pain arises from cen-
tral sensitization to the inputs of Ab fibers, whereas the
punctate hyperalgesia is due to a central sensitization
to the inputs of capsaicin-insensitive Ad nociceptors
(Magerl et al., 2001).
The tactile fibers have known convergence onto dorsal
horn cells that in addition receive inputs from nociceptive
primary afferents. The inputs from the nociceptors in
the injury zone are presumed to sensitize these so-called
wide-dynamic range neurons and thereby enhance the
synaptic efficacy of the tactile fibers. Nociceptive-spe-
cific neurons (dorsal horn neurons in lamina I) may be
sensitized in similar fashion.
Central sensitization to the inputs of tactile afferents in
patients has been demonstrated in patients with neuro-
pathic pain. A blood pressure cuff inflated in the proxi-
mal extremity leads to an orderly loss of sensation be-
ginning first with loss of tactile function. When this was
done in patients, the loss of tactile function coincided
with loss of allodynia (Campbell et al., 1988). It was
also noted that the detection of pain with tactile stimuli
was fast and indicated that primary afferents transmit-
ting the stimulus were likely in the A-b range.
Where Do the Abnormal Signals in Neuropathic
Pain Originate?
As shown in Figure 2, multiple sites along the neural axis
are altered after nerve injury. Abnormalities occur in the
injured and uninjured afferents supplying the affected
region. Central sensitization, similar to that discussed
above following tissue injury, is observed. In addition,
changes in descending control systems have been re-
ported. Finally, an immune response, both peripherally
and centrally, is observed.
A Role for Primary Afferents
The importance of primary afferent inputs in neuro-
pathic pain is strongly suggested by several pharmaco-
logical studies. For example, systemic administration of
AM1241, a selective CB2 cannabinoid receptor agonist,
results in reversal of signs of mechanical and thermal
hyperalgesia following an SNL lesion (Ibrahim et al.,
2003). Because CB2 is not expressed in the central ner-
vous system, the effects are likely due to a peripheral
mechanism.
Systemic administration of artemin dose-dependently
reversed the behavioral signs of neuropathic pain in
rats with an SNL injury (Gardell et al., 2003). Artemin
is a member of the glial-derived neurotrophic factor
(GDNF) family that signals through a common tyrosine
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81kinase receptor (RET) and GFRa3. GFRa3 is an acces-
sory protein that is predominantly expressed in small-di-
ameter, unmyelinated neurons (Orozco et al., 2001). The
artemin-induced changes in neuropathic pain behavior
are therefore most likely due to its action on nociceptive
primary afferents.
Antisense oligodeoxynucleotides (ODNs) directed
against Nav 1.8 reversed signs of mechanical hyperalge-
sia (Porreca et al., 1999). Nav 1.8 is a tetrodotoxin-resis-
tant sodium channel that is primarily expressed in small-
diameter primary afferent neurons. This treatment was
effective even when applied 6–14 days after nerve injury,
demonstrating that ongoing peripheral neuronal input is
critically involved in the maintenance of neuropathic
pain.
The Injured Afferent Hypothesis
The above evidence makes a clear case for the role of
primary afferents, and one might assume that the culprit
is the injured afferent itself. Indeed, much evidence fa-
vors this hypothesis. When nerve is injured a neuroma
forms. The spontaneous activity and ectopic sensitivity
to mechanical, thermal, and chemical stimuli that origi-
nate from the traumatic neuroma have been well docu-
mented (Blumberg and Ja¨nig, 1984; Devor, 2006a). Clin-
ical evidence has suggested that local-anesthetic
blockade of an injured nerve in patients relieves pain,
though no study, surprisingly, has really addressed
this issue in a well-designed blinded fashion (Arner
et al., 1990; Burchiel et al., 1993; Gracely et al., 1992;
Koltzenburg et al., 1994). Additional support for the role
Figure 2. A Spinal Nerve Injury Leads to Alterations at Many Sites
along the Neural Axis for Pain
Eight different sites of pathophysiological changes are shown. (1)
Spontaneous neural activity and ectopic sensitivity to mechanical
stimuli develops at the site of nerve injury. (2) The expression of dif-
ferent molecules in the dorsal root ganglion of the injured nerve is
up- or downregulated, reflecting the loss of trophic support from
the periphery. Spontaneous neural activity develops in the dorsal
root ganglia. (3) The distal part of the injured nerve undergoes Wal-
lerian degeneration, exposing the surviving nerve fibers from unin-
jured portions of the nerve to a milieu of cytokines and growth fac-
tors. (4) Partial denervation of the peripheral tissues leads to an
excess of trophic factors from the partly denervated tissue that
can lead to sensitization of primary afferent nociceptors. (5) The ex-
pression of different molecules in the dorsal root ganglion of the
uninjured nerve is up- or downregulated, reflecting the enhanced
trophic support from the periphery. (6) Sensitization of the postsyn-
aptic dorsal horn cell develops, leading to an augmentation of the re-
sponse to cutaneous stimuli. (7) Activated microglial cells contribute
to the development of this dorsal horn sensitization. (8) Changes in
descending modulation of dorsal horn neurons also may contribute
to the enhanced responsiveness of dorsal horn neurons.of injured afferents comes from experiments in the rat L5
SNL model in which anesthetics (Sukhotinsky et al.,
2004) or tetrodotoxin (TTX) (Lyu et al., 2000) directed at
the L5 ganglia reversed the neuropathic behavior.
Regardless of the reasonableness of the so-called
injured afferent hypothesis, several lines of evidence
suggest that there is more to the story.
Surprisingly, several authors report that the L5 SNL
model in rat leads to spontaneous activity in A fiber,
but not C fiber, afferents as recorded in the L5 dorsal
root (Boucher et al., 2000; Liu et al., 2000). This sponta-
neous activity in myelinated fibers appears to be pro-
duced mainly in afferents that (preinjury) serve muscle
and joint, but not skin (Michaelis et al., 2000; Proske
et al., 1995). These findings produce a dilemma because
activity in C fibers is thought to be necessary to evoke
the central sensitization mechanisms that account for
the hyperalgesia (Ji and Woolf, 2001). One possible ex-
planation is that A fiber-spontaneous activity can initiate
central sensitization after nerve injury, if the afferent un-
dergoes a phenotypic switch. A de novo expression of
neuropeptides normally only expressed in nociceptive
afferents could occur. For example, substance P immu-
noreactivity increases in large- and medium-size DRG
neurons after axotomy (Noguchi et al., 1994). However,
studies investigating substance P release from myelin-
ated afferents following nerve injury are inconclusive
(Allen et al., 1999; Malcangio et al., 2000). Another expla-
nation is that the spontaneous activity occurs in ‘‘A-b’’
nociceptors, the existence of which has been docu-
mented in rodent and primate (Djouhri and Lawson,
2004; Treede et al., 1998).
Other behavioral data suggest that signals originating
from the injured spinal nerve are not essential for hyper-
algesia to occur. An L5 dorsal rhizotomy immediately
before or after an L5 spinal nerve ligation did not prevent
or reverse neuropathic behavior (Eschenfelder et al.,
2000; Li et al., 2000). The counter to this observation is
that dorsal rhizotomy by itself may produce signs of me-
chanical hyperalgesia (Colburn et al., 1999; Eschen-
felder et al., 2000). More importantly, neuropathic pain
behavior is observed after an L5 ganglionectomy, where
the injured afferents are removed altogether (Sheth
et al., 2002). The prevailing message seems to be that
hyperalgesia can develop in the absence of neural activ-
ity from the injured nerve.
The Intact Nociceptor Hypothesis
According to this hypothesis, the intact nociceptors that
survive injury and that innervate the region affected by
the transected nerve fibers sensitize and have sponta-
neous activity. These changes in the intact nociceptors
may induce ongoing pain and may account for certain
aspects of hyperalgesia.
Following peripheral nerve lesions in primate and ro-
dent models, spontaneous activity developed in unin-
jured, unmyelinated nociceptive afferents that shared
the same innervation terrritory of the transected fibers
(Ali et al., 1999; Djouhri et al., 2006; Wu et al., 2001). Al-
though the average discharge frequency was low (seven
action potentials/5 min), the incidence of spontaneously
active fibers was high (50%). Low rates of spontaneous
activity may therefore assume importance if this phe-
nomenon is occurring in large numbers of C fibers, in
particular given the high convergence of C fiber input
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82in the CNS. Consistent with this hypothesis is the obser-
vation that low-frequency electrical stimulation in C fi-
bers can lead to hyperalgesia in humans (Klede et al.,
2003) and behavioral signs of hyperalgesia in rats (Wu
et al., 2002). The development of spontaneous activity
has also been observed in uninjured, myelinated affer-
ents in the L4 dorsal root (Boucher et al., 2000), and
this activity originated within the dorsal root ganglion.
Sensitization has also been reported in the intact no-
ciceptors. Following peripheral or spinal nerve lesion
in rat or rabbit, uninjured afferents develop adrenergic
sensitivity (Sato and Perl, 1991) and an increased sensi-
tivity to tumor necrosis factor-a (TNFa) (Scha¨fers et al.,
2003). One study has suggested that sensitization to
mechanical and heat stimuli occurs in the uninjured,
unmyelinated afferents as well (Shim et al., 2005). In-
creased responsiveness to heat stimuli could be due
to the observed increases in expression of mRNA and
protein for the transient receptor potential receptor V1
(TRPV1) in the DRG of uninjured afferents (Fukuoka
et al., 2000; Hudson et al., 2001). In addition, the inci-
dence of cold-responsive neurons in the L4 DRG is in-
creased after an L5 SNL (Djouhri et al., 2004), and there
is an increase in expression of the putative cold-sen-
sitive channel TRPA1 (Katsura et al., 2006). These ob-
servations may account for the occurrence of cooling
hyperalgesia seen in patients after nerve trauma.
One compelling line of evidence in favor of the intact
nociceptor hypothesis stems from experiments where
local treatments are applied to the partly denervated
skin. Local treatments can only affect the intact fibers.
In patients, local treatment with capsaicin may signifi-
cantly relieve ongoing pain. This is of interest because
the effects of capsaicin are specific to nociceptors. Ex-
periments with animal models point to similar conclu-
sions. Mibefradil, a T-type calcium-channel blocker, re-
versed mechanical and thermal hyperalgesia (Dogrul
et al., 2003), and local application of a glutamate recep-
tor antagonist reversed signs of thermal hyperalgesia
(Dogrul et al., 2000). In both studies, contralateral injec-
tions were without effects. Intraplantar injection of mor-
phine on the ipsilateral, but not contralateral, side signif-
icantly reversed mechanical allodynia (Pertovaara and
Wei, 2001).
The intact L4 dorsal root ganglion has been studied ex-
tensively to determine changes in phenotype after injury
to the adjacent L5 spinal nerve (L5 SNL). In addition to
increased expression of TRPV1 and TRPA1, mRNA for
calcitonin gene-related peptide (CGRP) is upregulated
(Fukuoka et al., 1998). Furthermore, the number of unin-
jured DRG neurons expressing brain-derived neurotro-
phic factor (BDNF) is increased (Fukuoka et al., 2001).
In the SNI model, there is an upregulation of P2X3
mRNA in uninjured neurons (Tsuzuki et al., 2001).
Sympathetically Maintained Pain and the Intact
Nociceptor Hypothesis
CRPS is a striking disorder manifest by severe pain typ-
ically in an extremity. Patients typically have edema, hy-
peralgesia, and may even have a motor disability that is
difficult to explain from a purely electrophysiological
perspective. In certain of these patients, selective anes-
thetic blockade of the sympathetic nervous system
leads to dramatic relief of pain (sympathetically main-
tained pain, or SMP). Blockade of a-adrenergic receptorfunction with intravenous infusion of the antagonist
phentolamine also leads to pain relief (Raja et al.,
1991). In patients with SMP, in whom a sympathetic
ganglion block was done to relieve pain and block re-
lease of norepinephrine, injection of physiological con-
centrations of norepinephrine evoked substantial pain
(Figure 3A).
In a primate model of neuropathic pain, an L6 SNL
leads to hyperalgesia just as it does in rodent models
(Carlton et al., 1994). About one-half of the afferents to
the top of the foot are lost, and the other half reach the
foot from the adjoining and putatively normal spinal
nerves (Ali et al., 1999). More than 60% of the intact
nociceptors had spontaneous activity (normally infre-
quently seen), and more than 50% had sensitivity
to the select a-adrenergic agonist phenylephrine (Fig-
ure 3B). These studies indicate that the mechanisms of
SMP relate to an adrenergic sensitization of nociceptors
(Figure 3C). Moreover, this chemical sensitization oc-
curs in the intact nociceptors that survive a proximal
nerve injury. Thus, SMP is a specific example of the im-
portance of the intact nociceptors in the pathogenesis of
a particular neuropathic pain disorder.
The Role of Growth Factors
Trophic factors in the target tissue have an ongoing
influence on sensory and motor fibers. Nerve injury in-
duces changes in growth-factor expression (Griffin,
2006). The change in expression occurs in the tissue
deprived of innervation (e.g., the skin), the Schwann
cells affected by Wallerian degeneration (denervated
Schwann cells), the DRG, and the dorsal horn. Of note,
in the SNL model, the L5 root is lesioned, but the L4
root shares the innervation territory, the same Schwann
cells, and has convergent input to dorsal horn cells
served by the L5 afferents. Nerve injury leads to in-
creased levels of NGF in the skin supplied by L4. The
binding of this NGF to the Trk-A receptors on the L4
fibers leads to transport of NGF back to the L4 DRG.
Evidence suggests that this increased level of NGF in
the L4 DRG affects factors such as BDNF. Indeed, the
changes in gene expression in the intact L4 DRG and
the lesioned L5 DRG are quite different.
Griffin has introduced the terms ‘‘undertrophed’’ and
‘‘overtrophed’’ to describe a putative mechanism by
which growth factors may dually affect both the injured
and uninjured afferents (Griffin, 2006). The injured axons
by losing connectivity with the peripheral tissues lose
trophic influences. The increased expression of trophic
factors in the denervated tissues on the other hand
‘‘overtroph’’ the remaining (intact) fibers. NGF might be
one of the villains in the case of overtrophing, whereas
GDNF might be the missing growth factor, absence of
which generates the pain-signaling mechanisms in the
injured L5 spinal nerve (Boucher and McMahon, 2001).
Transduction, Channel Function, and Ectopic
Discharge
Primary afferents transduce different forms of energy
into generator potentials. If of sufficient magnitude,
these generator potentials lead to action potentials.
The action potentials propagate along the axon to the
CNS. Pathological pain may result from disorders in-
volved in any of these steps.
There are two ways nociceptors may be sensitized.
One is for the transduction channel to sensitize (i.e., a
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The other mechanism regards a decrease in threshold
of the sodium channels responsible for spike initiation.
Figure 3. A Model for Sympathetically Maintained Pain
(A) After acutely relieving pain by performing a sympathetic block,
norepinephrine in physiological concentrations was injected intra-
dermally in a blinded fashion into the previously hyperalgesic area.
The norepinephrine injections into the affected, but not the unaf-
fected, extremity produced pain. Norepinephrine does not induce
pain in control subjects. These data suggest that the nociceptors
are sensitized to catechols in patients with SMP (adapted with per-
mission [Ali et al., 2000]). ACUC, area under curve.
(B) In primates, normal nociceptors do not respond to catechol ad-
ministration. However, in a monkey-spinal nerve ligation model, no-
ciceptors developed a response to the a1 adrenergic agonist phen-
ylephrine administered topically to their receptive field (adapted and
used with permission [Ali et al., 1999]). AP, action potentials.
(C) A model to account for SMP. After a partial nerve lesion, some af-
ferent fibers still remain in the skin. Factors released in the skin in-
duce the sympathetic efferents to sprout into more superficial areas
of the skin (Yen et al., 2006). These factors also lead the nociceptors
to express a1 adrenergic receptors. Now, the release of norepineph-
rine from the sympathetic terminals leads to activation of the noci-
ceptive terminals, which accounts for the coupling of sympathetic
activity with nociceptor responses.
Data are presented as mean 6 SEM.It is logical therefore to ask whether primary afferent
sensitization may account for features of neuropathic
pain. NGF regulates TRPV1 expression, and thus, over-
trophing mechanisms could link growth factors to trans-
duction-channel function (Cortright and Szallasi, 2004).
A role for TRPV4, a channel that may be involved in
transduction of mechanical stimuli, was suggested in
a neuropathic pain model produced by administration
of taxol (Alessandri-Haber et al., 2004). Abnormal trans-
duction, at least in part, likely underlies the pathophysi-
ology of the ‘‘intact nociceptor.’’ Sensitization of the ‘‘in-
tact’’ nociceptor in the SNL model may be responsible
for the hyperalgesia (Ringkamp and Meyer, 2006). An-
other mechanism relates to the acquisition of transduc-
tion capacity for stimuli that ordinarily do not activate
nociceptors. This has been clearly demonstrated in the
case of SMP, where intact nociceptors acquire sensitiv-
ity to norepinephrine. Cooling hyperalgesia is prominent
in neuropathic pain. Abnormal expression of transduc-
tion channels such as TRPA1, or TRPM8 in nociceptors,
could account for this phenomenon.
Transduction can be displaced to a point of nerve in-
jury as well. This misplaced transduction could account
for the so-called ‘‘Tinel sign,’’ a useful clinical finding,
wherein patients experience paresthesias (tingling sen-
sation) or dysthesthesia (an unpleasant or frankly painful
sensation) when the area over the nerve injury is tapped.
The Tinel sign may be present at a point of entrapment
where continuity of the axon has not necessarily been in-
terrupted. The presumed mechanism is that a distur-
bance of fast axonal transport (which serves as delivery
mechanism for newly synthesized transduction pro-
teins) leads to ectopic expression of the transduction
proteins. Axotomy leads to neuroma formation, where
budding regenerative nerve sprouts devoid of growth
guidance from denervated Schwann cells form an en-
tangled mass. Many neuromas are ‘‘painful,’’ but for un-
clear reasons (genetic factors, location?) many are not.
Areas of nerve injury may be tethered to adjacent mov-
ing structures (e.g., tendons), such that otherwise nor-
mal movements evoke an increase in pain presumably
by activating nociceptive afferents through activation
of mechanoreceptive transduction channels.
Nociceptorsensitization could also relate to changes in
voltage-gated sodium channels, particularly in the region
of spike initiation (Devor, 2006b). For example, if the
threshold for sodium-channel activation decreases, the
response to a given generator potential will be enhanced.
One reason for interest in sodium-channel function
centers on clinical evidence that drugs that affect so-
dium-channel function may be very effective in relieving
neuropathic pain. For example, the anticonvulsant car-
bamazepine, which works by stabilizing sodium chan-
nels in an inactive state, is considered the treatment of
choice for trigeminal neuralgia. The effects are consis-
tent enough that clinicians are trained to question the
diagnosis if the patient does not have at least some re-
sponse to the drug. As a class, each of the anticonvul-
sants that work through a sodium-channel mechanism
(lamotrigine, phenytoin, in addition to carbamazepine)
have some level of efficacy in neuropathic pain, though
side effects often preclude usefulness. Another class
of drugs that is effective in neuropathic pain is the local
anesthetics (Tremont-Lukats et al., 2006). At doses that
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may favorably affect neuropathic pain.
There are multiple types of voltage-gated sodium
channels that are expressed in the dorsal root ganglion
and may have a role in neuropathic pain. The channels
that have received greatest interest are Nav 1.3, 1.7,
1.8, and 1.9. These channels are found in small DRG
cells and therefore are likely involved in action potential
generation and conduction in nociceptors. Channels
Nav 1.3 and 1.7 are TTX sensitive, whereas Nav 1.8 and
1.9 are TTX insensitive. Some animal data suggest that
TTX given systemically may relieve hyperalgesia without
adversely affecting normal functions (Marcil et al., 2006).
Of the channels tested, only the TTX-sensitive channel
Nav 1.3 is upregulated in the DRG of the injured axons
(Black et al., 1999). This channel has kinetic properties
that could favor repetitive spiking.
Whereas prior efforts have concentrated on the a-
subunit expression, other complexities affect sodium-
channel function. Expression of the b subunits could
be part of this complexity. b2 subunits regulate channel
gating, assembly, and cell-surface expression of TTX-
sensitive channels. Expression of these subunits is in-
creased in injured sensory afferents (Pertin et al.,
2005), and in b2 null mice, mechanical hyperalgesia is
reduced in a spared nerve injury model. b2 null mice dis-
play marked reduction in TTX-sensitive sodium current
in small DRG neurons (Lopez-Santiago et al., 2006).
That channel function may strongly affect nociception
has been further emphasized by the discovery of the ge-
netic underpinnings of a striking neuropathic pain disor-
der known as erythromelalgia. Here, patients present
with profound heat hyperalgesia and ongoing burning
pain typically affecting the feet. The feet may also be in-
tensely red, indicating profound vasodilation. Point mu-
tations in the TTX-sensitive channel Nav1.7 account for
the disorder (Figure 4). These mutations lead to a hypo-
excitability in sympathetic neurons (accounting for the
increased perfusion in the feet) and a hyperexcitability
in small-sensory neurons (accounting for the pain and
hyperalgesia) (Rush et al., 2006). Release of vasoactive
peptides in the skin from the tonically active nociceptors
may also contribute to the vasodilatation.
The Role of Central Sensitization
Central sensitization refers to the augmented response
of central signaling neurons. Though thalamic and corti-
cal levels may be involved, most attention has focused
on the dorsal horn and in this review we will concentrate
on this area.
When it occurs as a result of inflammation, central
sensitization is strongly dependent on ongoing input
from nociceptors. Thus, if nociceptive input is blocked
in the injury zone, secondary hyperalgesia abates
promptly (LaMotte et al., 1991). This same dependence
on peripheral input probably also applies to central
sensitization associated with neuropathic pain, but this
issue requires further clarification. This distinction is of
great importance clinically. If mechanisms of pain are
completely centralized, it might be argued that attention
to peripheral mechanisms is unlikely to be therapeuti-
cally beneficial.
Central sensitization involves homosynaptic and het-
erosynaptic mechanisms (Magerl et al., 1998; Woolfet al., 1988). Homosynaptic sensitization means that
the conditioning stimulus and the test stimulus involve
the same input. In dorsal horn nociceptive neurons,
this is evident in a phenomenon referred to as ‘‘windup,’’
where continual low-frequency stimulation of C fiber af-
ferents leads to an increasing response in the dorsal
horn cell. Windup lasts tens of seconds and represents
a short-term form of sensitization.
Herterosynaptic sensitization means that the condi-
tioning stimulus and the test stimulus involve different
sets of afferents. Heterosynaptic sensitization accounts
for allodynia. Here, nociceptive inputs alter synaptic
efficacy such that A-b mechanoreceptors acquire the
capacity to evoke responses. Electrophysiological evi-
dence for heterosynaptic sensitization has been shown
in primate studies of dorsal horn cells where the re-
sponse to light stroking of the skin was enhanced after
capsaicin injection (Simone et al., 1991).
Ample evidence indicates that heterosynaptic and ho-
mosynaptic sensitization occur in neuropathic pain con-
ditions (Campbell et al., 1988; Ji et al., 2003). Figure 5
provides a model for how this may occur in the L5 SNL
model of neuropathic pain. Injured myelinated fibers
from the L5 root develop spontaneous activity. Some
Figure 4. A Genetic Basis for Erythromelalgia
(A) Schematic of the Nav 1.7 voltage-gated sodium channel that is
found exclusively in sensory and sympathetic neurons. A number
of point mutations have been identified in this sodium channel in
families of patients with erythromelalgia (Waxman and Dib-Hajj,
2005). The two mutations shown here produced single amino acid
substitutions at the sites indicated.
(B) Whole-cell-patch-clamp recordings in transfected HEK293 cells
revealed that these point mutations lead to an augmentation of
the response of the channel to a slow depolarizing ramp (100 mV
in 500 ms). These mutations would be expected to increase the
excitability of the peripheral sensory neuron. (Adapted with per-
mission [Cummins et al., 2004]. Copyright 2004 by the Society for
Neuroscience.).
Review
85of this activity could be in A-b mechanoreceptors (that
have acquired the capacity to release substance P) or
in A-d nociceptors. The input of these fibers onto cells
in the L5 segment could lead to homosynaptic sensitiza-
tion and enhanced ongoing activity. The enhanced ac-
tivity in L5 spinal thalamic tract cells could play a role
in ongoing pain sensation. The injured L5 afferents could
also project to the adjacent L4 segment where they
could produce heterosynaptic sensitization to input
from the L4 segment. This could account for the hyper-
algesia to mechanical and heat stimuli that is signaled by
activity in the intact L4 afferents.
Uninjured nociceptors in L4 root can develop sponta-
neous activity after an L5 SNL. This spontaneous activity
can lead to homosynaptic sensitization such that stimu-
lus-evoked activity in these nociceptors results in an
augmented response of the dorsal horn cells. The spon-
taneous activity in uninjured L4 nociceptors could also
produce heterosynaptic sensitization such that the re-
sponse of L4 spinal thalamic cells to L4 mechanorecep-
tor input is enhanced. A brush stimulus applied to the
foot activates the A-b fibers in the L4 root and acquires
the capacity to drive activity in the L4 dorsal horn cell,
consistent with heterosynaptic sensitization.
Homosynaptic and heterosynaptic sensitization in-
volve many mechanisms, but fundamentally these
mechanisms come down to two processes: (1) increased
release of excitatory neurotransmitter (e.g., glutamate,
substance P) and/or (2) enhanced synaptic efficacy.
These changes in turn may relate to several cellular
mechanisms (Basbaum, 1999). These mechanisms may
be considered in five categories: (1) presynaptic
Figure 5. Central Sensitization Mechanisms Involved in the Spinal
Nerve Ligation Model
Spontaneous activity from the injured afferents (L5) and intact noci-
ceptors (L4) may sensitize central pain-signaling neurons. The spon-
taneous activity in the L5 fibers is restricted to myelinated afferents.
Nociceptive C fibers from L4 spontaneously discharge and may
themselves be sensitized. The enhanced discharge of the primary
afferents leads to augmented response of dorsal horn cells to noci-
ceptor input and increased synaptic efficacy of inputs from mecha-
noreceptors (mechanism for allodynia). Alterations in descending
modulation and inhibitory interneuron function also likely play a role.changes, (2) postsynaptic changes, (3) interneuron
changes, (4) changes in descending modulation, and
(5) immune/microglial mechanisms (discussed in the
following section). Evidence suggests a role for each of
these mechanisms in neuropathic pain. Long-term po-
tentiation (LTP), a phenomenon that has received inten-
sive study in the hippocampus, appears to apply to the
dorsal horn to some degree. However, given the abnor-
mal ongoing input of primary afferents documented after
nerve injury, the acute central-sensitizing effects of pri-
mary afferents may have an ongoing role. Thus, both
short-term sensitization and LTP mechanisms likely ap-
ply. A role for long-term depression (LTD) in inhibitory
cells is also considered below.
Presynaptic Mechanisms
Release of glutamate is inhibited presynaptically by sev-
eral metabotropic G protein-coupled receptors, includ-
ing m-opioid receptors, GABA-b, and adenosine recep-
tors. Downregulation of m-opioid receptors has been
documented both pre- and postsynaptically after nerve
injury (Kohno et al., 2005) and could lead to an enhanced
release of glutamate.
Neurotransmitter release is triggered by voltage-
gated calcium channel activity on the central terminals
of primary afferents. Nerve injury leads to an upregula-
tion of the a-2-d subunit of these channels in the DRG
and spinal cord (Li et al., 2004). This could be associated
with increased calcium entry and augmented release of
glutamate. The anticonvulsant drugs gabapentin and
pregabalin are effective in neuropathic pain presumably
because they bind to and block this subunit (Bian et al.,
2006; Freynhagen et al., 2005). Although these drugs re-
verse hyperalgesia in neuropathic models, there is no
apparent effect on normal pain sensibility (Suzuki
et al., 2005). This argues for a special role of the a-2 sub-
unit in neuropathic pain.
There is also evidence to suggest that under condi-
tions of nerve injury, A-b fibers undergo a phenotypic
switch, such that they begin to express substance P
(Noguchi et al., 1994). As a consequence, stimulation
of these fibers leads to substance P release, providing
an additional potential mechanism for sensitization of
dorsal horn neurons.
Postsynaptic Mechanisms
There is excellent documentation of the role of postsyn-
aptic mechanisms in central sensitization. Slow depolar-
ization induced by substance P and other peptides
leads to an opening of the NMDA glutamate-gated chan-
nel, which in turn leads to calcium entry (Dougherty
et al., 1993; Duggan, 1995; Yoshimura and Yonehara,
2006). Calcium may gain entry through AMPA receptors
that do not contain the GluR2 subunit, as well, and this
mechanism may play a role in dorsal horn LTP (Gu
et al., 1996). A conditional knockdown of one NMDA
subunit, NR1, abolished hyperalgesia to formalin but
had no effect on normal pain sensibility (South et al.,
2003). Evidence exists for a multitude of intracellular
events linked to postsynaptic sensitization that result
from calcium entry. Protein kinases A and C and other
transcriptional factors likely play important roles in
these events (Kawasaki et al., 2004).
Another possible mechanism of postsynaptic sensi-
tization involves an increased trafficking of AMPA re-
ceptors to the cell surface. The expression of AMPA
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an SNL lesion (Harris et al., 1996). In addition, upregula-
tion of the mRNAs for both AMPA and NMDA receptors
has been demonstrated in diabetes (Tomiyama et al.,
2005).
We have suggested that allodynia stems from sensiti-
zation to the inputs of tactile afferents in the dorsal horn.
However, certain evidence suggests that the ‘‘Ab sensi-
tization’’ phenomenon may actually arise from alterna-
tive pathways. A lesion of the ipsilateral dorsal column
abolished mechanical hyperalgesia but, interestingly,
not heat hyperalgesia (Ossipov et al., 2002; Sun et al.,
2001). These data suggest that dorsal horn trafficking
may account for heat hyperalgesia but that other cen-
ters, such as the thalamus, may actually account for
the allodynia.
Role of Disinhibition Mechanisms
Inhibitory neurons play an important role in governing
the sensitivity of dorsal horn neurons (Gu et al., 1996).
Decreased expression of inhibitory receptors (on pri-
mary afferent terminals and postsynaptic neurons) has
been noted following nerve injury, and sensitization
could result from this disinhibition mechanism (Kohno
et al., 2005). Several other mechanisms involving inhibi-
tory interneurons have been suggested. We have dis-
cussed LTP. The reciprocal phenomenon is LTD. Salter
has suggested that LTD may be evoked by activation
of NMDA receptors present on GABAergic cells due to
differential expression of the subunits in the NMDA
receptor (Salter, 2006). LTD in inhibitory cells may lead
to central sensitization (Randic et al., 1993). To what
extent this mechanism applies to the dorsal horn is
unclear.
Nerve injury also induces a downregulation of the po-
tassium-chloride transporter KCC2. This trans-synaptic
effect on superficial dorsal horn cells (presumed projec-
tion neurons of the spinothalamic tract), leads to a less-
negative equilibrium potential for chloride, such that
opening the chloride channel with GABA induces depo-
larization sufficient to induce excitation. Consistent with
this finding, knockdown of the expression of KCC2 leads
to hyperalgesia (Coull et al., 2003).
Further evidence indicates that nerve injury induces
a selective apoptosis of inhibitory GABAergic inter-
neurons (Moore et al., 2002). Apoptosis of inhibitory
GABAergic neurons argues for a hard-wire change in cir-
cuitry (Scholz et al., 2005). This is a critical therapeutic
issue. If central sensitization evolves such that nocicep-
tive signaling becomes independent of inputs from pri-
mary afferents, then treating the peripheral nerve may
no longer be therapeutically useful. Moreover, the rela-
tive importance of peripheral and central mechanisms
may well depend on the underlying disease. Some
diseases may involve primary afferents as well as the
CNS. An example is postherpetic neuralgia where
damage may extend from the primary afferents to the
dorsal horn.
Descending Modulatory Mechanisms
Descending modulatory pathways also appear to influ-
ence dorsal horn sensitization mechanisms in neuro-
pathic pain. Cortical, thalamic, and periaqueductal
inputs converge on the rostroventromedial medulla
(RVM). This center gives rise to both inhibitory and excit-
atory inputs to the dorsal horn via an ipsilateral pathwayin the dorsolateral funiculus (DLF). Many of the cells in
the RVM express m-opioid receptors. Selective ablation
of these cells either before or after establishment of the
SNL model can eliminate hyperalgesia (Porreca et al.,
2001). Lidocaine microinjection (Burgess et al., 2002)
and hemisection experiments (Bian et al., 1998) have
yielded similar results.
Supraspinal Mechanisms
Recent fMRI studies reveal changes in the processing of
cutaneous stimuli at supraspinal centers in conditions
of hyperalgesia and allodynia. Experimental studies of
secondary hyperalgesia allow the comparison of fMRI
images before and after the development of hyperalge-
sia. In these studies, mechanical stimulation of the skin
produced enhanced pain in the zone of secondary hy-
peralgesia and led to enhanced activation in areas of
the brain associated with pain signaling (Baron et al.,
1999; Maihofner et al., 2004). Whether these changes
in supraspinal processing are passive or whether they
reflect additional plasticity mechanisms is difficult to
know. Functional imaging studies in patients with neuro-
pathic pain reveal that light stroking that produces pain
recruits a complex cortical network, including nocicep-
tive, motor, and cognitive areas (Maihofner et al., 2006;
Schweinhardt et al., 2006). Functional imaging may
lead to new insights into the mechanisms of neuropathic
pain as well as to objective measures of altered sensa-
tions (Borsook et al., 2004).
The Immune System and Neuropathic Pain
Clearly the immune system is critical to the pain associ-
ated with inflammatory pain. The immune system ap-
pears to play a critical role in neuropathic pain as well
(Marchand et al., 2005). Nude rats that lack mature T cells
had diminished hyperalgesia (Moalem et al., 2004).
Passive transfer of type 1, but not type 2, T cells led to
similar levels of hyperalgesia as those seen in rats with
intact T cell function. In addition, cytokines, Il-1, Il-6,
and TNFa all have demonstrated roles in neuropathic
pain (Manning, 2006). Several variables are worth noting
in approaching the question of immune mechanisms.
 One must distinguish the immune mechanisms as-
sociated with a particular disease from the immune
mechanisms that are particular to the issue of neu-
ropathic pain.
 Immune mechanisms need to be considered sepa-
rately in terms of what happens in the peripheral
nervous system versus those that are important
in the central nervous system.
 Finally, immune mechanisms may play a role in ini-
tiating neuropathic pain, maintaining neuropathic
pain acutely, and/or play a role in chronic neuro-
pathic pain.
Peripheral Immune Mechanisms
Nociceptors have a rich variety of immune receptors,
and evidence exists for roles of the interleukins (IL-1b
and IL-6), TNFa, bradykinin, prostanoids, and others
(Opree and Kress, 2000). In the CCI model of neuro-
pathic pain, a ’’neuritis’’ develops, likely reflecting the
inflammatory response to the suture material (Kleinsch-
nitz et al., 2004). In this model, immune mechanisms
might be a particular issue simply because of the foreign
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happens with simple surgical axotomy (e.g., the SNL
model).
Nerve damage evokes a cascade of immune re-
sponses. Nerve damage leads to macrophage infiltra-
tion, T cell activation, and increased expression of proin-
flammatory cytokines. With axotomy, Schwann cells are
in a sense denervated. These denervated Schwann cells
(as well as cells in the partially denervated target tissue)
may communicate with intact fibers that pass within the
same nerve. This provides a mechanism by which to
explain changes in the intact nociceptor (see above).
Schwann cell denervation recruits macrophages via se-
cretion of leukemia inhibitory factor (LIF) and monocyte
chemoattractant protein-1 (MCP-1) (Sugiura et al.,
2000). MCP-1 serves as a ligand for CCR2 (Tofaris
et al., 2002). CCR2 knockout mice do not develop me-
chanical hyperalgesia after a partial nerve ligation injury
(Abbadie et al., 2003). Cytokine IL-1b leads to increased
expression of nerve growth factor (NGF), and NGF may
sensitize nociceptors (Kanaan et al., 1998). Knockout
of the IL-1 receptor type I and genetically mediated
overexpression of an IL-1 receptor antagonist de-
creased hyperalgesia. That the effect was peripheral
was supported by the observation that spontaneous ac-
tivity recorded from the dorsal root fibers was reduced
(Wolf et al., 2006).
TNFa has received much attention as a culprit in
neuropathic pain. Endoneurial administration induces
hyperalgesia (Wagner and Myers, 1996). Preemptive
treatment with the TNF-sequestering drug etanercept
decreases hyperalgesia but has no effect once hyperal-
gesia is established (Sommer et al., 2001). TNFa can ini-
tiate activity in nociceptors (Sorkin et al., 1997). Inhibi-
tion of TNFa blocks phosphorylation of the MAP
kinase p38 in DRG and hyperalgesia but again only
when given preemptively (Scha¨fers et al., 2003). Another
cytokine that has received attention is IL-6. A role in the
CCI model has been suggested (Okamoto et al., 2001),
but other peripheral actions are unclear at present.
Central Immune Mechanisms
Somewhat surprising is the mounting evidence that cen-
tral immune mechanisms play a role in neuropathic pain
(Figure 6) (Watkins and Maier, 2005). As with peripheral
mechanisms, much evidence supports the view that ini-
tiation, but not maintenance, of neuropathic pain behav-
iors is associated with immune mechanisms (Xu et al.,
2006). Microglia serve as the macrophages of the CNS.
Nerve injury distal to the dorsal root ganglia leads to
microglial activation. However, activation after dorsal
rhizotomy is much less, in keeping with the observation
that dorsal rhizotomy leads to less-impressive hyperal-
gesia compared to spinal nerve lesions involving the
identical root (Willis et al., 2006). Interthecal delivery of
the antibiotic minocycline, an inhibitor of microglial
activation, attenuates neuropathic pain (Raghavendra
et al., 2003).
The mechanisms are far from clear. Nociceptor activ-
ity leads to rapid activation of the MAP kinase ERK in mi-
croglia and initially not in other central cells (Tsuda et al.,
2005). Inhibition of this activation attenuates pain behav-
ior. The mechanisms for this activation might be multi-
factorial. Evidence exists for a role of the ATP receptors
P2X4 and/or P2X7, both of which are expressed onmicroglia. The chemokine fractalkine may also be in-
volved, as blockade of its receptor, CX3CR1, attenuates
hyperalgesia in neuropathic pain models (Milligan et al.,
2005). The activated microglia produce the toxic cyto-
kines IL-1, IL-6, and TNFa as well as nitric oxide, excit-
atory amino acids, ATP, and prostaglandins (Inoue,
2006).
The toll-like receptor-4 (TLR4) is a molecule involved
in the innate immune response and is mainly expressed
on microglia. Spinal mRNA for TLR4 is increased after L5
SNL. A knockout or point mutation in TLR4, as well as
downregulation through intrathecal delivery of anti-
sense ODN, has a significant effect on neuropathic
pain behavior, but only when given in the early stages
(Tanga et al., 2005).
Conclusion
We began this review by presenting a patient with chest-
wall pain following a mastectomy. The simultaneous
finding of decreased sensation and ongoing pain was
suggested to be a paradox. Animal models, as well as
studies in humans, however, have taken us a long way
toward understanding this case of neuropathic pain. On-
going pain likely represents spontaneous discharge in
afferents. The injured afferents are an obvious source
of abnormal input.
Sodium-channel dysfunction likely plays an important
role in leading to ectopic generation of action potentials.
The patient had episodes of abrupt ‘‘pain attacks.’’
These attacks may correspond to bursts of spontane-
ous activity in the injured afferents related to sodium-
channel dysfunction. Somewhat surprisingly, however,
the intact afferents that share the innervation territory
of the injured afferents also discharge spontaneously.
Studies of their cell bodies in the DRG reveal striking
phenotype changes. Trophic factors released from the
partly denervated skin working through their receptors
on the peripheral terminals may account for these ab-
normalities. The abnormalities seen in these ‘‘intact’’ no-
ciceptors likely account for the fact that patients such as
this may respond to therapies applied at the level of the
skin. Central changes also play a role in neuropathic
pain. Many of the mechanisms probably are the same
as those observed with inflammatory pain. The patient
had pain and hyperalgesia well outside the region of
nerve injury. This is precisely the case in inflammatory
pain, where secondary hyperalgesia extends well be-
yond the injury site. The patient had substantial pain
Figure 6. Microglial Cells in the CNS Are Activated following Periph-
eral Nerve Injury and Release Cytokines that Alter the Responses of
Dorsal Horn Cells
Neuron
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lines of evidence indicate that this allodynia is due to
central sensitization, such that tactile afferents acquire
synaptic efficacy, which enables them to trigger activity
in central pain signaling neurons. Prevailing work has fo-
cused on the dorsal horn as the site for this sensitization,
but more rostral pathways may be involved as well.
Though not easily understood as yet, peripheral nerve
injury induces some striking transynaptic effects. One
is apoptosis that appears to preferentially affect GABA
inhibitory cells. Several lines of evidence indicate that
immune mechanisms are involved both peripherally
and centrally. Activation of microglial cells occurs in
the dorsal horn, and this activation may play a vital
role in initiating central sensitization. The role of this ac-
tivation in ongoing neuropathic pain is less clear. The
sensation of pain begins with a simple thesis: nocicep-
tors encode information about noxious stimuli and prop-
agate these messages to the CNS and pain is felt. In the
case of neuropathic pain, however, we see that a rich
biology is at play. Studies are quickly uncovering the
mechanisms, and no longer can we consider the pres-
ence of this problem quite so mysterious.
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